Charlotte's Web Holdings (CWBHF) Capital Expenditures (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Capital Expenditures came in at $21000.0 in Q1 2026, down 95.97% year-on-year from $521000.0 in Q1 2025, and up 120.79% on a QoQ basis from -$101000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Capital Expenditures (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Capital Expenditures data on file, last reported at $21000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 95.97% year-over-year to $21000.0 in Q1 2026; TTM through Mar 2026 was $49000.0, a 97.88% decrease from a year earlier, with the FY2025 full-year figure at $549000.0, down 85.74% from the prior year.
- Capital Expenditures for Q1 2026 stood at $21000.0, up from -$101000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for CWBHF reached as high as $2.8 million in Q3 2023 and fell as low as -$146000.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $523562.5 across 5 years, with a median of $203500.0 in 2023.
- Across the five-year window, Capital Expenditures sank 1560.0% in 2022 and jumped 3525.64% in 2023, its largest moves.
- Year by year, Capital Expenditures stood at -$146000.0 in 2022, then soared by 563.01% to $676000.0 in 2023, then tumbled by 67.46% to $220000.0 in 2024, then slumped by 145.91% to -$101000.0 in 2025, then soared by 120.79% to $21000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $21000.0 in Q1 2026, -$101000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 676,000.00 |
| Dec 31, 2023 | 676,000.00 |